PacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 Million

Stock Information for Pacific Biosciences of California Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Pacific Biosciences of California Inc.

PacBio Announces Major Advances for Revio and Vega to Lower Genome Cost and Expand Multiomic Capabilities
PacBio HiFi Technology Selected as Core Platform for South Korea's National Pangenome Project
Long Life Family Study Taps PacBio HiFi Sequencing to Unlock Genetic and Epigenetic Clues to Exceptional Longevity
PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs
PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes
PacBio and EpiCypher Partner to Deliver Novel Insights into Epigenomics with Fiber-seq Workflow
PacBio Announces Second Quarter 2025 Financial Results
PacBio to Present at Upcoming Investor Conferences

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.